EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieVergleichsstudieMultizentrische Studie

Characterization of cardiovascular serious adverse events after bypass or endovascular revascularization for limb-threatening ischemia in the BEST-CLI trial

Jeffrey J Siracuse, Matthew T Menard, Kenneth Rosenfield, Michael S Conte, Richard Powell, Naomi Hamburg, Gheorghe Doros, Michael B Strong, Alik Farber

Journal of Vascular Surgery · 2024-09 · 80 (3) · 774-779

DOI: 10.1016/j.jvs.2024.04.025 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Vascular Surgery, 2024-09. Verfasst von Jeffrey J Siracuse und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Vascular and Endovascular Surgery, Boston Medical Center, Boston University Chobanian and Avedisian School of Medicine, Boston, MA. Elect…. Hauptthemen laut MEDLINE: Chronic Limb-Threatening Ischemia, Endovascular Procedures, Vascular Grafting, Postoperative Complications. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 17 Literaturangaben. Gefördert von: NHLBI NIH HHS, NHLBI.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chronic Limb-Threatening IschemiaEndovascular ProceduresVascular GraftingPostoperative ComplicationsHeart DiseasesAgedFemaleHumansMaleMiddle AgedProspective StudiesRisk AssessmentRisk FactorsTime FactorsTreatment Outcome

Stichwörter der Autor:innen

BypassCardiovascularEndovascular

Autor:innen und Institutionen

  • Division of Vascular and Endovascular Surgery, Boston Medical Center, Boston University Chobanian and Avedisian School of Medicine, Boston, MA. Electronic address: Jeffrey.Siracuse@bmc.org.
  • Division of Vascular and Endovascular Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
  • Section of Vascular Medicine and Intervention Massachusetts General Hospital, Harvard Medical School, Boston, MA.
  • Division of Vascular and Endovascular Surgery, University of California, San Francisco, San Francisco, CA.
  • Division of Vascular and Endovascular Surgery, Dartmouth-Hitchcock Medical Center, Lebanon, NH.
  • Division of Cardiovascular Medicine, Boston Medical Center, Boston University Chobanian and Avedisian School of Medicine, Boston, MA.

Förderung

  • NHLBI NIH HHS
  • NHLBI

Zitieren

APA

Siracuse, J. J., Menard, M. T., Rosenfield, K., Conte, M. S., Powell, R., Hamburg, N., Doros, G., Strong, M. B., & Farber, A. (2024). Characterization of cardiovascular serious adverse events after bypass or endovascular revascularization for limb-threatening ischemia in the BEST-CLI trial. Journal of Vascular Surgery, 80(3), 774-779. https://doi.org/10.1016/j.jvs.2024.04.025

Vancouver

Siracuse JJ, Menard MT, Rosenfield K, Conte MS, Powell R, Hamburg N, et al. Characterization of cardiovascular serious adverse events after bypass or endovascular revascularization for limb-threatening ischemia in the BEST-CLI trial. Journal of Vascular Surgery. 2024;80(3):774-779. doi:10.1016/j.jvs.2024.04.025

BibTeX
@article{Siracuse2024,
  author = {Siracuse, Jeffrey J and Menard, Matthew T and Rosenfield, Kenneth and Conte, Michael S and Powell, Richard and Hamburg, Naomi and Doros, Gheorghe and Strong, Michael B and Farber, Alik},
  title = {Characterization of cardiovascular serious adverse events after bypass or endovascular revascularization for limb-threatening ischemia in the BEST-CLI trial},
  journal = {Journal of Vascular Surgery},
  year = {2024},
  volume = {80},
  number = {3},
  pages = {774--779},
  doi = {10.1016/j.jvs.2024.04.025}
}
Kostenlos starten →